Friedenthal Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Friedenthal Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Buy	1,805 +1,751	+3,243%	+$237K	0.13%	103
2026 Q1	$6.9K	Sell	54 -1,177	-96%	-$147K	﹤0.01%	193
2025 Q4	$150K	Buy	+1,231	New	+$141K	0.08%	121
2024 Q4	–	Sell	-1,189	Closed	-$117K	–	334
2024 Q3	$117K	Buy	+1,189	New	+$117K	0.07%	124
2024 Q2	–	Sell	-1,305	Closed	-$124K	–	295
2024 Q1	$124K	Buy	1,305 +17	+1%	+$1.58K	0.08%	120
2023 Q4	$115K	Buy	+1,288	New	+$95.7K	0.08%	117
2022 Q4	–	Sell	-60,856	Closed	-$4.83M	–	116
2022 Q3	$4.83M	Buy	+60,856	New	+$5.13M	3.36%	14
2021 Q2	–	Sell	-41,652	Closed	-$5.65M	–	74
2021 Q1	$5.65M	Buy	+41,652	New	+$6.24M	4.16%	9
2020 Q1	–	Sell	-46,110	Closed	-$4.39M	–	55
2019 Q4	$4.39M	Buy	+46,110	New	+$3.99M	3.34%	8

Other funds holding XBI

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Friedenthal Financial's XBI Position: Q2 2026 in Review

Friedenthal Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3,243% in Q2 2026, buying an estimated $237K and bringing the position to 1,805 shares worth $286K. The position accounts for 0.13% of the portfolio, ranked #103.

Friedenthal Financial first reported a position in XBI in Q4 2019 and has held it in 9 quarters since. The position peaked at $5.65M in Q1 2021. 368 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Friedenthal Financial held 1,805 shares of State Street SPDR S&P Biotech ETF worth $286K as of Q2 2026.
Friedenthal Financial bought 1,751 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $237K.
State Street SPDR S&P Biotech ETF made up 0.13% of Friedenthal Financial's portfolio in Q2 2026, its #103 holding.
Friedenthal Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 9 quarters since.
Friedenthal Financial's State Street SPDR S&P Biotech ETF position peaked at $5.65M in Q1 2021.
368 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Friedenthal Financial's 13F filing for Q2 2026, filed 13 Jul 2026.